3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation

Molecular and Cellular Biochemistry

Volumn 358, Issue 1-2, 2011, Pages 345-354

  Jin, Yucui ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

Author keywords

3 3 Diindolylmethane (DIM); Breast cancer; Cdc25A; MiR 21

Indexed keywords

3,3' DIINDOLYLMETHANE; 3,3'-DIINDOLYLMETHANE; CELL CYCLE PROTEIN; INDOLE DERIVATIVE; MICRORNA; MIRN21 MICRORNA, HUMAN; PROTEIN TYROSINE PHOSPHATASE; SERINE;

ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PROTEIN DEGRADATION; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CDC25 PHOSPHATASES; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; INDOLES; MICE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PROTEOLYSIS; SERINE; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84857145850     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0985-0     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
2. Gandini S, Merzenich H, Robertson C, Boyle P (2000) Metaanalysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36:636-646
3. Sun J, Liu RH (2008) Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation. J Agric Food Chem 56:11661-11667
4. Holst B, Williamson G (2004) A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep 21:425-447
5. Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4:1201-1215
6. Hong C, Firestone GL, Bjeldanes LF (2002) Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in humanbreast cancer cells. Biochem Pharmacol 63:1085-1097
7. Sarkar FH, Li Y (2004) Indole-3-carbinol and prostate cancer. J Nutr 134:3493S-3498S
8. Bohlig L, Friedrich M, Engeland K (2011) p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res 39:440-453
9. Malhas A, Saunders NJ, Vaux DJ (2010) The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation. Cell Cycle 9:531-539
10. Saxena S, Jonsson ZO, Dutta A (2003) Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278:44312-44319
11. Ambros V (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113:673-676
12. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7:464-473
13. Li Y, VandenBoom TG 2nd, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69:6704-6712
14. Melkamu T, Zhang X, Tan J, Zeng Y, Kassie F (2010) Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3- carbinol. Carcinogenesis 31:252-258
15. Strickley RG (2004) Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201-230
16. Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, Yudelev M, Joiner MC, Marples B, Forman JD, Sarkar FH (2004) Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther 3:1271-1279
17. Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH (2006) Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCIDhuman mouse model. Mol Cancer Ther 5:2747-2756
18. Ahmad A, Kong D, Wang Z, Sarkar SH, Banerjee S, Sarkar FH (2009) Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. J Cell Biochem 108:916-925
19. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF (2005) 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778
20. Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J (2002) Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 21:5911-5920
21. Melixetian M, Klein DK, Sorensen CS, Helin K (2009) NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat Cell Biol 11:1247-1253
22. Li M, Yin S, Yuan J, Wei L, Ai JS, Hou Y, Chen DY, Sun QY (2008) Cdc25A promotes G2/M transition in oocytes. Cell Cycle 7:1301-1302
23. Boutros R, Dozier C, Ducommun B (2006) The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18:185-191
24. Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 7:495-507
25. Wu Y, Feng X, Jin Y, Wu Z, Hankey W, Paisie C, Li L, Liu F, Barsky SH, Zhang W, Ganju R, Zou X (2010) A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation. Cancer Prev Res (Phila Pa) 3:818-828
26. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ Jr, Lazo JS, Wang Z, Zhang L, Yu J (2009) microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69:8157-8165
27. Okino ST, Pookot D, Basak S, Dahiya R (2009) Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention. Cancer Prev Res (Phila) 2:251-256
28. Xue L, Firestone GL, Bjeldanes LF (2005) DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24: 2343-2353
29. Gong Y, Sohn H, Xue L, Firestone GL, Bjeldanes LF (2006) 3,3'- Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res 66:4880-4887
30. Degner SC, Papoutsis AJ, Selmin O, Romagnolo DF (2009) Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3′-diindolylmethane in breast cancer cells. J Nutr 139:26-32
31. Chen I, McDougal A, Wang F, Safe S (1998) Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19:1631-1639
32. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501
33. Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Dulic V (2004) p21-Mediated nuclear retention of cyclin B1- Cdk1 in response to genotoxic stress. Mol Biol Cell 15: 3965-3976
34. Sadhu K, Reed SI, Richardson H, Russell P (1990) Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci USA 87:5139-5143
35. Cangi MG, Cukor B, Soung P, Signoretti S, Moreira G Jr, Ranashinge M, Cady B, Pagano M, Loda M (2000) Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 106:753-761
36. Evans KL (2000) Overexpression of CDC25A associated with poor prognosis in breast cancer. Mol Med Today 6:459
37. Goloudina A, Yamaguchi H, Chervyakova DB, Appella E, Fornace AJ Jr, Bulavin DV (2003) Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle 2:473-478
38. Jallepalli PV, Lengauer C, Vogelstein B, Bunz F (2003) The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J Biol Chem 278:20475-20479
39. Rossi L, Bonmassar E, Faraoni I (2007) Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56:248-253
40. Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, Jaspers NG, van Gent DC, Hoeijmakers JH, Persengiev SP (2009) MicroRNA-mediated gene silencing modulates the UVinduced DNA-damage response. EMBO J 28:2090-2099